ask Ask a question
Favorite

This is a single-arm, open-label, pilot intervention study to investigate the effects of 5-ALA/SFC in patients with MDM. We created the present study design in accordance with Standard Protocol Items: Recommendations for Interventional Trials and Consolidated Standards of Reporting Trials 2010 guidelines.[11,12]

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A